GSK Plc (GSK)
59.12
-0.14
(-0.24%)
USD |
NYSE |
Feb 24, 16:00
59.06
-0.06
(-0.10%)
After-Hours: 20:00
GSK Research and Development Expense (Quarterly) : 3.112B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AstraZeneca PLC | 3.725B |
| Mereo BioPharma Group Plc | 4.243M |
| Novavax, Inc. | 98.17M |
| Biodexa Pharmaceuticals Plc | -- |
| AnaptysBio, Inc. | 31.27M |